Autor: "Papadaki, C." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
Autorzy:: Makrakis D; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Jacobi Medical Center, Albert Einstein College of Medicine, The Bronx, NY, United States of America.
Rounis K; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
Tsigkas AP; Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece.
Georgiou A; Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece.
Galanakis N; Department of Medical Imaging, University General Hospital, Heraklion, Crete, Greece.
Tsakonas G; Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Ekman S; Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Papadaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.
Monastirioti A; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.
Kontogianni M; Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University, Athens, Greece.
Gioulbasanis I; Department of Medical Oncology, Animus Kyanus Stavros General Clinic, Larissa, Greece.
Mavroudis D; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.
Agelaki S; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Feb 10; Vol. 18 (2), pp. e0277708. Date of Electronic Publication: 2023 Feb 10 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Male ; Female ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Programmed Cell Death 1 Receptor ; Prospective Studies ; Prognosis ; Obesity ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.
Autorzy:: Monastirioti A; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.
Papadaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.
Rounis K; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece.
Kalapanida D; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece.
Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece.
Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece.; Pokaż więcej
Źródło:: Cells [Cells] 2021 Aug 05; Vol. 10 (8). Date of Electronic Publication: 2021 Aug 05.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Macrophage Activation*
Biomarkers, Tumor/*blood
Carcinoma, Non-Small-Cell Lung/*blood
Circulating MicroRNA/*blood
Lung Neoplasms/*blood
Tumor-Associated Macrophages/*metabolism
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/pathology ; Disease Progression ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/immunology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Progression-Free Survival ; Retrospective Studies ; Time Factors ; Tumor Microenvironment ; Tumor-Associated Macrophages/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
Autorzy:: Rounis K; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.
Makrakis D; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Division of Oncology, University of Washington Medical School, Seattle, Washington, United States of America.
Papadaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Monastirioti A; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Vamvakas L; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.
Kalbakis K; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.
Gourlia K; Department of Computer Science, University of Crete, Heraklion, Crete, Greece.
Xanthopoulos I; Department of Computer Science, University of Crete, Heraklion, Crete, Greece.
Tsamardinos I; Department of Computer Science, University of Crete, Heraklion, Crete, Greece.
Mavroudis D; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Agelaki S; Department of Medical Oncology, University General Hospital, Heraklion, Crete, Greece.; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Jun 01; Vol. 16 (6), pp. e0252537. Date of Electronic Publication: 2021 Jun 01 (Print Publication: 2021).
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Bacterial Agents/*adverse effects
B7-H1 Antigen/*antagonists & inhibitors
Bone Neoplasms/*secondary
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Non-Small-Cell Lung/*pathology
Immune Checkpoint Inhibitors/*administration & dosage
Immunotherapy/*methods
Liver Neoplasms/*secondary
Lung Neoplasms/*drug therapy
Lung Neoplasms/*pathology
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/mortality ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Machine Learning ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Autorzy:: Kalikaki A; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete , Heraklion, Crete , Greece , 1.
Voutsina A
Koutsopoulos A
Papadaki C
Sfakianaki M
Yachnakis E
Xyrafas A
Kotsakis A
Agelaki S
Souglakos J
Mavroudis D
Georgoulias V; Pokaż więcej
Źródło:: Cancer investigation [Cancer Invest] 2015 Apr; Vol. 33 (4), pp. 107-13. Date of Electronic Publication: 2015 Feb 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Polymorphism, Single Nucleotide*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Biomarkers, Tumor/*genetics
Carcinoma, Non-Small-Cell Lung/*drug therapy
DNA-Binding Proteins/*genetics
Endonucleases/*genetics
Lung Neoplasms/*drug therapy
Adult ; Aged ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Platinum/administration & dosage ; RNA, Messenger/analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
Autorzy:: Papadaki C; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Sfakianaki M; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Lagoudaki E; Department of Pathology, University General Hospital of Heraklion, Heraklion, 71110 Crete, Greece.
Giagkas G; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Ioannidis G; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Trypaki M; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Tsakalaki E; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Voutsina A; Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece.
Koutsopoulos A; Department of Pathology, University General Hospital of Heraklion, Heraklion, 71110 Crete, Greece.
Mavroudis D; 1] Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece [2] Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, 71110 Crete, Greece.
Georgoulias V; 1] Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece [2] Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, 71110 Crete, Greece.
Souglakos J; 1] Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece [2] Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, 71110 Crete, Greece.; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2014 Oct 28; Vol. 111 (9), pp. 1757-64. Date of Electronic Publication: 2014 Sep 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Biomarkers, Tumor/*metabolism
Carcinoma, Non-Small-Cell Lung/*metabolism
Carcinoma, Squamous Cell/*metabolism
Carrier Proteins/*metabolism
Lung Neoplasms/*metabolism
Membrane Proteins/*metabolism
Thyroid Hormones/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Bevacizumab ; Biomarkers, Tumor/genetics ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/secondary ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/secondary ; Carrier Proteins/genetics ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Docetaxel ; Female ; Follow-Up Studies ; Glutamates/administration & dosage ; Guanine/administration & dosage ; Guanine/analogs & derivatives ; Humans ; Immunoenzyme Techniques ; Lung Neoplasms/drug therapy ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Lymphatic Metastasis ; Male ; Membrane Proteins/genetics ; Middle Aged ; Neoplasm Staging ; Pemetrexed ; Platinum/administration & dosage ; Prognosis ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Survival Rate ; Taxoids/administration & dosage ; Thyroid Hormones/genetics ; Gemcitabine ; Thyroid Hormone-Binding Proteins